The U.S. Supreme Court cut the time it will take for copycat versions of biologic drugs to get to the market in a pivotal ruling about an expensive class of medicines.
New cancer drugs that target genetic mutations regardless of where the tumor is growing should expand the practice of testing patients for such glitches, oncology experts say.
Study: Nearly 60 Percent of Employees with Access to a Company Wellness Program Say the Initiative Has Made a Positive Impact on Their Health
Most employees with access to workplace wellness programs say they have made a positive impact on their health, even though a majority are unwilling to devote more than one hour per day to health-related activities such as consistent exercise, according to a new survey.
Sanofi pledged to peg U.S. drug price rises to below healthcare inflation, limits 2017 increases to 5.4 percent.
The Justice Department accused UnitedHealth of obtaining inflated risk adjustment payments based on inaccurate info about patients’ health status.
UnitedHealth Group Inc. reported stronger-than-expected first-quarter 2017 results and said it was coping with uncertainty in U.S. healthcare laws by pricing its 2018 insurance plans to include a costly Obamacare tax.
The Trump administration issued a final rule that will shorten the Obamacare enrollment period and give insurers more of what they say they need in the individual insurance market, likely making it harder for some consumers to purchase insurance, healthcare experts said.
A federal judge dismissed two of the six counterclaims that Express Scripts raised in health insurer’s Anthem’s $15 billion lawsuit claiming it charged too much for drugs.
President Donald Trump told several chief executives of large insurance companies that 2017 will be a “catastrophic” year for the Affordable Care Act as he seeks to make good on a campaign promise to repeal the measure.
The U.S. Justice Department joined a whistleblower lawsuit against UnitedHealth Group Inc. that claims the country’s largest health insurer and its units and affiliates overcharged Medicare hundreds of millions of dollars, a law firm representing the whistleblower said.